You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

chronic hepatitis C virus genotype 3

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis C, Hepatitis C Virus, Genotype 3 Hepatitis C Virus Trial (ABT-493/ABT-530, Sofosbuvir, Daclatasvir)

Completed
Has Results
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 9, 2021

Chronic Hepatitis C Virus Infection Trial (OBV/PTV/r, Sofosbuvir, Ribavirin (RBV))

Completed
Has Results
  • Chronic Hepatitis C Virus Infection
  • (no location specified)
Jul 8, 2021

Chronic Hepatitis c Genotype 1 Trial in Moscow, Saint Petersburg (Narlaprevir, Ritonavir, Sofosbuvir)

Completed
  • Chronic Hepatitis c Genotype 1
  • Moscow, Russian Federation
  • +4 more
Oct 27, 2022

Seroconversion of Hepatitis c Virus Among CKD on Regular

Not yet recruiting
  • Hepatitis C Virus
    • (no location specified)
    Oct 25, 2023

    Hepatitis C Trial in Bradford, London, Nottingham (Telaprevir, 40 Kd Pegylated interferon alfa 2a, Ribavirin)

    Completed
    • Hepatitis C
    • Bradford, United Kingdom
    • +3 more
    Jan 4, 2023

    Occult Hepatitis C Virus Infection in Patients Born Before 1969

    Not yet recruiting
    • Hepatitis C, Chronic
    • +2 more
    • Meridan Bioscience Point of Care test against HCV antibodies
    • (no location specified)
    Apr 2, 2023

    Chronic Hepatitis C Virus, Hepatitis C Virus Trial (ABT-493/ABT-530, sofosbuvir (SOF), ribavirin (RBV))

    Completed
    Has Results
    • Chronic Hepatitis C Virus
    • Hepatitis C Virus
    • (no location specified)
    Jul 14, 2021

    Hepatitis C, HCV Trial in San Antonio (TD-6450, Placebo)

    Completed
    • Hepatitis C
    • HCV
    • San Antonio, Texas
      Texas Liver Institute
    Jan 15, 2021

    Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-493 coformulated with

    Completed
    Has Results
    • Hepatitis C Virus Infection
    • +3 more
    • ABT-493 coformulated with ABT-530
    • (no location specified)
    Jul 9, 2021

    Chronic Hepatitis C Virus (HCV) Infection Trial (ABT-493/ABT-530, Placebo for ABT-493/ABT-530)

    Completed
    Has Results
    • Chronic Hepatitis C Virus (HCV) Infection
    • (no location specified)
    Jul 14, 2021

    Hepatitis C Virus Infection, Chronic Hepatitis C, Compensated Cirrhosis Trial (ABT-493/ABT-530)

    Completed
    Has Results
    • Hepatitis C Virus Infection
    • +2 more
    • (no location specified)
    Jul 9, 2021

    Hepatitis C, Chronic Trial in Carlsbad (ISIS 14803)

    Completed
    • Hepatitis C, Chronic
    • ISIS 14803
    • Carlsbad, California
      Isis Pharmaceuticals
    Dec 1, 2022

    Liver Cancer Trial in Houston (Bevacizumab, Atezolizumab, Sofosbuvir)

    Not yet recruiting
    • Liver Cancer
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 9, 2023

    Hepatitis C Virus Trial (ABT-493/ABT-530)

    Completed
    Has Results
    • Hepatitis C Virus
    • (no location specified)
    Jul 9, 2021

    Determine Hepatitis C Virus Infection Prevalence Among Patients

    Completed
    • Chronic Hepatitis c
    • Vasculitis
      • Mexico City, Mexico
        Hospital General de Mexico
      Mar 15, 2022

      Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (Ombitasvir/Paritaprevir/Ritonavir, Dasabuvir)

      Completed
      Has Results
      • Chronic Hepatitis C Infection
      • Compensated Cirrhosis
      • (no location specified)
      Jul 8, 2021

      Chronic Hepatitis C Virus Infection Trial in China, Korea, Republic of, Taiwan (P1101 + Ribavirin, PEG-Intron + Ribavirin)

      Completed
      • Chronic Hepatitis C Virus Infection
      • P1101 + Ribavirin
      • PEG-Intron + Ribavirin
      • Beijing, China
      • +38 more
      Jan 14, 2022

      Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493/ABT-530)

      Completed
      Has Results
      • Chronic Hepatitis C
      • +2 more
      • (no location specified)
      Jul 9, 2021

      Chronic Hepatitis C Virus (HCV) Infection Genotype 1 Trial in United States (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

      Completed
      Has Results
      • Chronic Hepatitis C Virus (HCV) Infection Genotype 1
      • Phoenix, Arizona
      • +47 more
      Jun 27, 2022

      Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530)

      Completed
      Has Results
      • Chronic Hepatitis C
      • +2 more
      • (no location specified)
      Jul 9, 2021

      Hepatitis C Virus Trial in Korea, Republic of, Russian Federation, Taiwan (DCV/ASV/BMS-791325)

      Completed
      Has Results
      • Hepatitis C Virus
      • Busan, Korea, Republic of
      • +19 more
      Oct 27, 2020

      Zepatier in Patients With Substance Use

      Active, not recruiting
      • Hepatitis C
      • +3 more
      • Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
      • Chicago, Illinois
        University of Illinois at Chicago
      Jun 28, 2022

      Chronic Hepatitis C Virus, Hepatitis C, Chronic, Hepatitis C Trial in Bucuresti (Bemnifosbuvir, Ruzasvir)

      Recruiting
      • Chronic Hepatitis C Virus
      • +4 more
      • Bucuresti, BUC, Romania
        Atea Study Site
      Jun 15, 2023

      Chronic Hepatitis, Hepatitis C Infection Trial in Puerto Rico, United States (Electroporation-Mediated Plasmid DNA Vaccine

      Active, not recruiting
      • Chronic Hepatitis
      • Hepatitis C Infection
      • Electroporation-Mediated Plasmid DNA Vaccine Therapy
      • +4 more
      • Jacksonville, Florida
      • +4 more
      Sep 20, 2022

      HCV Trial in Beijing (Ravidasvir, Danoprevir, Ritonavir)

      Completed
      • HCV
      • Beijing, Beijing, China
        Peking University People's hospital
      Jul 25, 2020